| Phenylephrine |
II-4001/19,01,2009 г. |
Mydfrin, Eye drops, solution, 125, mg, Pack: 1 |
Алкон България ЕООД, България |
S.A. Alcon Couvreur N.V., Белгия / Alcon Laboratories, Inc., САЩ |
7.84 |
1.57 |
9.41 |
7% |
0.55 |
8.39 |
1.68 |
10.07 |
20% |
1.57 |
9.96 |
1.99 |
11.95 |
цената е заличена с решение НСР-8000/08.02.2016. (в сила от 02.03.2016) |
КЦ-665/05.03.2009 |
19.03.2009 |
19.03.2009 |
Заличен |
582 |
| Tolperisone |
II-12366/13.02.2006 |
MYDOCALM, Film coated tablet, 150 mg, mg, Pack: 30 |
Gedeon Richter Plc., Унгария |
Gedeon Richter Plc., Hungary |
4.34 |
0.87 |
5.21 |
7% |
0.3 |
4.64 |
0.93 |
5.57 |
20% |
0.87 |
5.51 |
1.1 |
6.61 |
|
КЦ-351/19.12.2008 |
27.01.2009 |
27.01.2009 |
Активен |
356 |
| Mycophenolic acid |
EU/1/07/438/003 |
Myfenax, Tablet, 500, mg, Pack: 50 |
Teva Pharma B.V., Нидерландия |
Teva Pharmaceutical Work Private Limited Company, Hungary; Teva UK Limited, UK Pharmachemie BV- The Netherlands; Teva Sante SA, France |
28.59 |
5.72 |
34.31 |
6% |
1.72 |
30.31 |
6.06 |
36.37 |
18% |
5.15 |
35.46 |
7.09 |
42.55 |
Цената се заличава с решение НСР-3165/27.03.2014(допуска предварително изпълнение) |
НСР-2330/13.01.2014 |
11.02.2014 |
11.02.2014 |
Заличен |
2459 |
| Mycophenolic acid |
EU/1/07/438/003 |
Myfenax, Tablet, 500, mg, Pack: 50 |
Teva Pharma B.V., Нидерландия |
Teva Pharmaceutical Work Private Limited Company, Hungary; Teva UK Limited, UK Pharmachemie BV- The Netherlands; Teva Sante SA, France |
88.87 |
17.77 |
106.64 |
4% |
3.55 |
92.42 |
18.48 |
110.9 |
16% |
14.22 |
106.64 |
21.33 |
127.97 |
|
КЦ-2656/29.08.2011 |
13.09.2011 |
13.09.2011 |
Неактивен |
2459 |
| Mycophenolic acid |
EU/1/07/438/001 |
Myfenax, Capsule, hard, 250, mg, Pack: 100 |
Teva Pharma B.V., Нидерландия |
Teva Pharmaceutical Work Private Limited Company, Hungary ; Teva UK Limited, UK Pharmachemie BV- The Netherlands; Teva Sante SA, France |
33.99 |
6.8 |
40.79 |
4% |
1.36 |
35.35 |
7.07 |
42.42 |
16% |
5.44 |
40.79 |
8.16 |
48.95 |
Цената се заличава с решение НСР-3165/27.03.2014(допуска предварително изпълнение) |
НСР-2330/13.01.2014 |
11.02.2014 |
11.02.2014 |
Заличен |
2460 |
| Mycophenolic acid |
EU/1/07/438/001 |
Myfenax, Capsule, hard, 250, mg, Pack: 100 |
Teva Pharma B.V., Нидерландия |
Teva Pharmaceutical Work Private Limited Company, Hungary ; Teva UK Limited, UK Pharmachemie BV- The Netherlands; Teva Sante SA, France |
88.87 |
17.77 |
106.64 |
4% |
3.55 |
92.42 |
18.48 |
110.9 |
16% |
14.22 |
106.64 |
21.33 |
127.97 |
|
КЦ-2656/29.08.2011 |
13.09.2011 |
13.09.2011 |
Неактивен |
2460 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
141.35 |
28.27 |
169.62 |
4% |
5.65 |
147 |
29.4 |
176.4 |
16% |
22.62 |
169.62 |
33.92 |
203.54 |
|
НСР-8221/22.02.2016; НСР-10758/27.10.2016 |
02.12.2016 |
02.12.2016 |
Активен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
150.21 |
30.04 |
180.25 |
4% |
6.01 |
156.22 |
31.24 |
187.46 |
16% |
24.03 |
180.25 |
36.05 |
216.3 |
НСР-9086/21.04.2016 e корекционно решение на HCP-8221/22.02.2016. ; корекционно решение НСР-9086/21.04.2016 |
НСР-8221/22.02.2016 |
09.03.2016 |
09.03.2016 |
Неактивен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
150.21 |
30.04 |
180.25 |
4% |
6.01 |
156.22 |
31.24 |
187.46 |
16% |
24.03 |
180.25 |
36.05 |
216.3 |
|
НСР-8221/22.02.2016 |
09.03.2016 |
09.03.2016 |
Неактивен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
160.55 |
32.11 |
192.66 |
4% |
6.42 |
166.97 |
33.39 |
200.36 |
16% |
25 |
191.97 |
38.39 |
230.36 |
|
НСР-6230/21.05.2015 |
04.06.2015 |
04.06.2015 |
Неактивен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
170.57 |
34.11 |
204.68 |
4% |
6.82 |
177.39 |
35.48 |
212.87 |
16% |
25 |
202.39 |
40.48 |
242.87 |
|
НСР-3049/21.03.2014 |
08.04.2014 |
08.04.2014 |
Неактивен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
228.66 |
45.73 |
274.39 |
4% |
9.15 |
237.81 |
47.56 |
285.37 |
16% |
25 |
262.81 |
52.56 |
315.37 |
|
КЦРР-921/04.07.2012 |
19.07.2012 |
19.07.2012 |
Неактивен |
2647 |
| Mycophenolic acid |
0387/02.08.2007 г. |
Myfortic, Gastro resistant tablet, 180, mg, Pack: 120 |
Novartis Pharma GmbH, Германия |
Novartis Pharma S.A.S., Франция |
242.25 |
48.45 |
290.7 |
6% |
14.54 |
256.79 |
51.36 |
308.15 |
18% |
30 |
286.79 |
57.36 |
344.15 |
|
КЦ-480/29.01.2009 |
16.02.2009 |
16.02.2009 |
Неактивен |
2647 |
| Doxorubicin |
EU/1/00/141/001 |
Myocet, Powder, dispersion and solvent for concentrate for dispersion for infusion, 50, mg, Pack: 2 |
Teva B.V., Нидерландия |
GP-Pharma Poligon Industrial Els Vinyets – Els Fogars, Sector 2, Carretera Comarcal C244, km22 08777 Sant Quinti de Mediona (Barcelona) Spain; Teva Operations Poland Sp. z o.o., ul. Mogilska 80, 31-546 |
1708.34 |
341.67 |
2050.01 |
4% |
10 |
1718.34 |
343.67 |
2062.01 |
16% |
25 |
1743.34 |
348.67 |
2092.01 |
промяна на обстоятелства НСР-6874/30.07.2015 |
НСР-5292/ 18.12.2014. |
01.01.2015 |
01.01.2015 |
Активен |
3463 |
| Doxorubicin |
EU/1/00/141/001 |
Myocet, Powder, dispersion and solvent for concentrate for dispersion for infusion, 50, mg, Pack: 2 |
Teva Pharma B.V., Нидерландия |
GP-Pharma Poligon Industrial Els Vinyets – Els Fogars, Sector 2, Carretera Comarcal C244, km22 08777 Sant Quinti de Mediona (Barcelona) Spain; Teva Operations Poland Sp. z o.o., ul. Mogilska 80, 31-546 |
1735.72 |
347.14 |
2082.86 |
4% |
10 |
1745.72 |
349.14 |
2094.86 |
16% |
25 |
1770.72 |
354.14 |
2124.86 |
|
НСР-3355/29.04.2014 |
13.05.2014 |
13.05.2014 |
Неактивен |
3463 |
| Doxorubicin |
EU/1/12/769/001EU/1/00/141/001 |
Myocet, Powder, dispersion and solvent for concentrate for dispersion for infusion, 50, mg, Pack: 2 |
Teva Pharma B.V., Нидерландия |
GP-Pharma Poligon Industrial Els Vinyets – Els Fogars, Sector 2, Carretera Comarcal C244, km22 08777 Sant Quinti de Mediona (Barcelona) Spain; Teva Operations Poland Sp. z o.o., ul. Mogilska 80, 31-546 |
1774.88 |
354.98 |
2129.86 |
4% |
10 |
1784.88 |
356.98 |
2141.86 |
16% |
25 |
1809.88 |
361.98 |
2171.86 |
промяна на осбстоятелства НСР-1009/16.08.2013 |
НСР-990/16.08.2013 |
04.09.2013 |
04.09.2013 |
Неактивен |
3463 |
| Doxorubicin |
EU/1/12/769/001EU/1/00/141/001 |
Myocet, Powder, dispersion and solvent for concentrate for dispersion for infusion, 50, mg, Pack: 2 |
Cephalon Europe, Франция |
GP-Pharma Poligon Industrial Els Vinyets – Els Fogars, Sector 2, Carretera Comarcal C244, km22 08777 Sant Quinti de Mediona (Barcelona) Spain; Teva Operations Poland Sp. z o.o., ul. Mogilska 80, 31-546 |
1865.16 |
373.03 |
2238.19 |
4% |
10 |
1875.16 |
375.03 |
2250.19 |
16% |
25 |
1900.16 |
380.03 |
2280.19 |
|
КЦРР-1702/27.11.2012 |
12.12.2012 |
12.12.2012 |
Неактивен |
3463 |
| Technetium [99mTc] tetrofosmin |
II-15004/24.11.2006 |
Myoview, Powder for solution for injection, 230, mcg, Pack: 5 vial (kit for radiopharmaceutical preparation) |
GE Healthcare Ltd, Обединено Кралство |
GE Healthcare Limited |
1093.31 |
218.66 |
1311.97 |
4% |
10 |
1103.31 |
220.66 |
1323.97 |
16% |
25 |
1128.31 |
225.66 |
1353.97 |
|
КЦ-823/15.04.2009 |
30.04.2009 |
30.04.2009 |
Активен |
711 |
| Alglucosidase alfa |
EU/1/06/333/001 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
832.99 |
166.6 |
999.59 |
4% |
10 |
842.99 |
168.6 |
1011.59 |
16% |
25 |
867.99 |
173.6 |
1041.59 |
|
НСР-8521/16.03.2016 |
31.03.2016 |
31.03.2016 |
Активен |
3264 |
| Alglucosidase alfa |
EU/1/06/333/001 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
832.99 |
166.6 |
999.59 |
4% |
10 |
842.99 |
168.6 |
1011.59 |
16% |
25 |
867.99 |
173.6 |
1041.59 |
|
НСР-8521/16.03.2016 |
31.03.2016 |
31.03.2016 |
Неактивен |
3264 |
| Alglucosidase alfa |
EU/1/06/333/001 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
838.58 |
167.72 |
1006.3 |
4% |
10 |
848.58 |
169.72 |
1018.3 |
16% |
25 |
873.58 |
174.72 |
1048.3 |
|
НСР-6598/01.07.2015 |
17.07.2015 |
17.07.2015 |
Неактивен |
3264 |
| Alglucosidase alfa |
EU/1/06/333/001 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd., UK |
844.06 |
168.81 |
1012.87 |
4% |
10 |
854.06 |
170.81 |
1024.87 |
16% |
25 |
879.06 |
175.81 |
1054.87 |
|
НСР-4936/22.10.2014 |
06.11.2014 |
06.11.2014 |
Неактивен |
3264 |
| Alglucosidase alfa |
EU/1/06/333/001 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd. UK |
862.15 |
172.43 |
1034.58 |
4% |
10 |
872.15 |
174.43 |
1046.58 |
16% |
25 |
897.15 |
179.43 |
1076.58 |
корекц. Решение НСР-3158/26.03.2014 |
НСР-2771/17.02.2014 |
06.03.2014 |
06.03.2014 |
Неактивен |
3264 |
| Alglucosidase alfa |
EU/1/06/333/001-003 |
Myozyme, Powder for concentrate for solution for infusion, 50, mg, Pack: 1 |
Genzyme Europe B.V., Нидерландия |
Genzyme Ltd. UK |
916.27 |
183.25 |
1099.52 |
4% |
10 |
926.27 |
185.25 |
1111.52 |
16% |
25 |
951.27 |
190.25 |
1141.52 |
|
HCР-18/31.05.2013 |
02.06.2013 |
02.06.2013 |
Неактивен |
3264 |
| Galsulfase |
EU/1/05/324/001 |
Naglazyme, Concentrate for solution for infusion, 1mg/ml, 5 ml, Pack: 1 |
BioMarin Europe Limited, Обединено Кралство |
Catalent UK Packaging Ltd, Великобритания |
2543.38 |
508.68 |
3052.06 |
4% |
10 |
2553.38 |
510.68 |
3064.06 |
16% |
25 |
2578.38 |
515.68 |
3094.06 |
корекционно решение НСР-6891/30.07.2015; цената е вписана в регистъра на пределните цени с решение НСР-7947/08.02.2016 г.(в сила от 02.03.2016) |
НСР-6483/18.06.2015 |
04.07.2015 |
04.07.2015 |
Заличен |
3285 |